scholarly journals Analysis of the factors affecting the results of arteriovenous fistula surgery

2021 ◽  
Vol 54 (3) ◽  
pp. 155-158
Author(s):  
Daisuke Oka ◽  
Yoshitaka Sekine ◽  
Akira Ohtsu ◽  
Masanori Aoki ◽  
Takuma Hayashi ◽  
...  
Keyword(s):  
Arteriovenous Fistula ◽  
Factors Affecting ◽  
Fistula Surgery

Principles of Dural Arteriovenous Fistula Surgery

2016 ◽  
Author(s):  
Thomas Wilson ◽  
Stacey Wolfe ◽  
Aaron Cohen-Gadol
Keyword(s):  
Arteriovenous Fistula ◽  
Dural Arteriovenous Fistula ◽  
Fistula Surgery

A Prospective Clinical Evaluation of the Effects of Intraoperative Systemic Anticoagulation in Patients Undergoing Arteriovenous Fistula Surgery

2010 ◽  
Vol 76 (10) ◽  
pp. 1112-1114 ◽  
Author(s):  
Bonnie R. Wang ◽  
Vincent L. Rowe ◽  
Sung Wan Ham ◽  
Sukgu Han ◽  
Kaushal Patel ◽  
...  
Keyword(s):  
Arteriovenous Fistula ◽  
Postoperative Bleeding ◽  
Bleeding Complications ◽  
Controlled Study ◽  
Control Group ◽  
Heparin Group ◽  
Av Fistula ◽  
Fistula Surgery ◽  
Significant Difference ◽  
The Difference

No standard presently exists for the use of systemic heparin during angioaccess surgery to decrease the incidence of postoperative thrombotic complications. Our objective was to study the effects of intraoperatively administered heparin on 30-day patency and postoperative bleeding complications in patients undergoing autogenous arteriovenous (AV) fistula surgery. A prospective, double-blinded, randomized controlled study was performed on 48 patients undergoing AV fistula creation from April 2007 through November 2009. Of the 48 patients, 22 were randomized to the control group and received no heparin. Twenty-six were randomized to receive heparin (75 units/kg intravenously) before clamping of the artery. There was no significant difference in 30-day patency between the heparin and control groups (92% vs 86%, P = 0.65), respectively. Three patients (12%) developed hematomas in the heparin group compared with one (5%) in the control group; however the difference was not statistically significant ( P = 0.61). The results suggest that intraoperative administration of heparin has no statistically significant effect on 30-day patency rates or postoperative bleeding complications. Larger trials with longer term follow-up and assessment of maturation rates are needed to determine the effect of intraoperative anticoagulation on these outcomes of arteriovenous fistula surgery.

scholarly journals Upper limb exercise for people on haemodialysis following arteriovenous fistula surgery

2019 ◽  
Author(s):  
Termpong Reanpang ◽  
Mujalin Prasannarong ◽  
Sasinat Pongtam ◽  
Scott T Murray ◽  
Kittipan Rerkasem
Keyword(s):  
Arteriovenous Fistula ◽  
Upper Limb ◽  
Fistula Surgery ◽  
Limb Exercise

Troponin before and after arteriovenous fistula surgery performed under loco-regional anaesthesia

2019 ◽  
Vol 36 (5) ◽  
pp. 380-381
Author(s):  
Emilie Ellies ◽  
Xavier Raingeval ◽  
Etiennette De Fouchécour ◽  
Patrick Lanter ◽  
Frédéric Le Saché
Keyword(s):  
Arteriovenous Fistula ◽  
Regional Anaesthesia ◽  
Fistula Surgery ◽  
Before And After

Regional Anesthesia for Arteriovenous Fistula Surgery May Reduce Hospital Length of Stay and Reoperation Rates

2018 ◽  
Vol 52 (6) ◽  
pp. 418-426 ◽  
Author(s):  
Naida M. Cole ◽  
Kamen Vlassakov ◽  
Ethan Y. Brovman ◽  
Mahyar Heydarpour ◽  
Richard D. Urman
Keyword(s):  
Length Of Stay ◽  
General Anesthesia ◽  
Arteriovenous Fistula ◽  
Regional Anesthesia ◽  
Lower Risk ◽  
Anesthesia Care ◽  
Monitored Anesthesia Care ◽  
Improvement Project ◽  
Fistula Surgery ◽  
Postoperative Length

Background and Objectives: Regional anesthesia has been proposed as the preferred mode of anesthesia for arteriovenous fistula surgery due to its associated vasodilatory effects and fistula patency rates. We analyzed patient outcomes after arteriovenous fistula surgery for their association with the type of anesthesia received. Methods: The National Surgical Quality Improvement Project database was accessed to identify a cohort of 3199 patients undergoing arteriovenous fistula surgery from 2007 to 2015. Multiple regression models were used to examine the association of anesthesia with 12 postoperative outcomes. Additional multivariate logistic regression was performed to assess significant independent variables predictive of anesthesia choice. Results: Patients who received regional anesthesia had the shortest postoperative length of stay (0.67 [standard deviation: 2.0] days) compared to monitored anesthesia care/intravenous (IV) sedation (0.77 [1.8] days) and general anesthesia (1.44 [2.8] days). Administration of regional anesthesia was associated with a shorter length of stay compared to general anesthesia (odds ratio [OR]: 0.55, P = .001). Patients who received monitored anesthesia care/IV sedation had a lower risk of reoperation compared to general anesthesia (OR: 0.65, P = .012) but not compared to regional anesthesia (OR: 0.89, P = .759). Anesthesia type had no significant effects on other measured postoperative complications. Predictors of the type of anesthesia were age and surgical procedure as defined by Current Procedural Terminology code ( P < .001). Conclusions: Use of regional anesthesia is associated with a shorter postoperative length of stay after arteriovenous fistula surgery and lower risk of reoperation compared to general anesthesia or monitored anesthesia care/IV sedation. Regional anesthesia may be an excellent choice for arteriovenous fistula surgery to reduce postoperative length of stay and risk of reoperation.

Sign in / Sign up

Export Citation Format

Share Document